Humira

Evolution step-up growth trajectory upward trajectory
Pharma

How biosimilar developers are embracing next phase of US market

Although the so-called biosimilar ‘void’ could pose challenges to upcoming biosimilar availability, the opportunity it presents is also immense.
AbbVie

AbbVie shrugs off new J&J competition for fast-growing Skyrizi

Apr 29, 2026 2:53pm
AbbVie

AbbVie launches ‘PSO Done’ psoriasis campaign

Apr 20, 2026 8:03am
AbbVie

AbbVie touts Skyrizi, Rinvoq prowess amid J&J IBD competition

Feb 4, 2026 2:52pm
AbbVie

AbbVie locks in US pricing deal as it pledges $100B investment

Jan 13, 2026 9:15am
drug prices biologics drug costs IRA money cash payment co-pay

Inside the turning tides of the US biosimilar market

Jan 8, 2026 9:00am